BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20023263)

  • 1. Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics.
    Cioc AM; Wagner JE; MacMillan ML; DeFor T; Hirsch B
    Am J Clin Pathol; 2010 Jan; 133(1):92-100. PubMed ID: 20023263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
    Mehta PA; Harris RE; Davies SM; Kim MO; Mueller R; Lampkin B; Mo J; Myers K; Smolarek TA
    Cancer Genet Cytogenet; 2010 Dec; 203(2):180-6. PubMed ID: 21156231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor.
    Tönnies H; Huber S; Kuhl JS; Gerlach A; Ebell W; Neitzel H
    Blood; 2003 May; 101(10):3872-4. PubMed ID: 12511406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome abnormalities in bone marrow of Fanconi anemia patients.
    Berger R; Le Coniat M; Schaison G
    Cancer Genet Cytogenet; 1993 Jan; 65(1):47-50. PubMed ID: 8431915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fanconi anemia: myelodysplasia as a predictor of outcome.
    Alter BP; Caruso JP; Drachtman RA; Uchida T; Velagaleti GV; Elghetany MT
    Cancer Genet Cytogenet; 2000 Mar; 117(2):125-31. PubMed ID: 10704682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment of Primary Adult MDS Nested Case-Control Study Cohort and Study of Risk Factors Associated with MDS Evolution to Leukemia].
    Ma Y; Chen BB; Wang XQ; Xu XP; Lin GW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1638-46. PubMed ID: 26708886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
    Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
    Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of Myelodysplastic Syndrome in Patients Evaluated for Cytopenia(s). A Report from a Reference Centre in Saudi Arabia.
    AlMozain N; Mashi A; Alneami Q; Al-Omran A; Bakshi N; Owaidah T; Khalil S; Khogeer H; Hashmi S; Al-Sweedan S; Morris T; AlNounou R
    Hematol Oncol Stem Cell Ther; 2022 Jun; 15(2):39-44. PubMed ID: 33227261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions.
    Quentin S; Cuccuini W; Ceccaldi R; Nibourel O; Pondarre C; Pagès MP; Vasquez N; Dubois d'Enghien C; Larghero J; Peffault de Latour R; Rocha V; Dalle JH; Schneider P; Michallet M; Michel G; Baruchel A; Sigaux F; Gluckman E; Leblanc T; Stoppa-Lyonnet D; Preudhomme C; Socié G; Soulier J
    Blood; 2011 Apr; 117(15):e161-70. PubMed ID: 21325596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q- syndrome from refractory anemia in primary myelodysplastic syndrome.
    Cermák J; Michalová K; Brezinová J; Zemanová Z
    Leuk Res; 2003 Mar; 27(3):221-9. PubMed ID: 12537974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes.
    Chaubey R; Sazawal S; Dada R; Mahapatra M; Saxena R
    Indian J Med Res; 2011 Oct; 134(4):452-7. PubMed ID: 22089606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of the Clonal Fraction by Fluorescence In Situ Hybridization in Myelodysplastic Syndrome: Comparison With International Working Group Treatment Response Criteria.
    Park JH; Kim M; Kong SY; Yoon SS; Lee DS
    Arch Pathol Lab Med; 2016 Jun; 140(6):560-9. PubMed ID: 27232348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytogenetic peculiarity of chromosomal abnormalities in myelodisplastic syndromes in childhood].
    Andreeva SV
    Lik Sprava; 2011; (5-6):71-9. PubMed ID: 22606895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An uncommon t(9;11)(p24;q22) with monoallelic loss of
    Lovatel VL; de Souza DC; Alvarenga TF; Capela de Matos RR; Diniz C; Schramm MT; Llerena Júnior JC; Silva MLM; Abdelhay E; de Souza Fernandez T
    Mol Cytogenet; 2018; 11():40. PubMed ID: 30008805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia.
    Lensch MW; Rathbun RK; Olson SB; Jones GR; Bagby GC
    Leukemia; 1999 Nov; 13(11):1784-9. PubMed ID: 10557053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clonal chromosomal aberrations in patients with aplastic anemia at the disease onset and transformation].
    Ol'shanskaia IuV; Mikhaĭlova EA; Domracheva EV; Udovichenko AI; Davidian IuR; Vodinskaia LA; Zakharova AV; Kokhno AV; Kaplanskaia IB; Tikhonova LIu; Tsvetaeva NV; Parovichnikova EN; Savchenko VG
    Ter Arkh; 2006; 78(7):31-4, 36-7. PubMed ID: 16944748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Cytogenetic Approach to Characterize Novel and Cryptic Chromosome Abnormalities in Childhood Myeloid Malignances of Fanconi Anemia.
    Borges ML; Capela de Matos RR; Amaral BD; Soares-Ventura EM; Leite EP; Silva MO; Cornélio MT; Silva ML; Liehr T; Marques-Salles TD
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):e85-e91. PubMed ID: 28212262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
    Maciejewski JP; Risitano A; Sloand EM; Nunez O; Young NS
    Blood; 2002 May; 99(9):3129-35. PubMed ID: 11964274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.